ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

For decades, relaxor ferroelectrics have powered everything from medical ultrasounds to sonar systems, yet their inner atomic ...

Building on a long-standing MIT-IBM collaboration, the new lab will chart the convergence of AI, algorithms, and quantum ...

Artificial intelligence systems based on neural networks—such as ChatGPT, Claude, DeepSeek or Gemini—are extraordinarily ...

The following is a joint announcement by the MIT Schwarzman College of Computing and IBM.IBM and MIT today announced the ...

Due to the explosive growth of artificial intelligence, it is estimated that data centers will consume up to 12% of total U.S ...

The Israeli military has used a targeting system powered by artificial intelligence to launch what it says are attacks on ...

Using artificial intelligence, engineers at the University of California San Diego have developed a new way to watch the ...

Chemists and computer scientists tapped AI to find new disinfectants to combat the growing threat of dangerous "superbugs." ...

This article explores how building structured, connected data systems is essential to unlocking reliable insights, accelerating innovation, and turning AI into a consistent driver of value.

For every life-changing new drug that comes to market, many candidates fail along the way. An artificial intelligence-based ...

From executive shakeups to "Agentic Ready" payments, the industry's biggest players are pivoting to meet the next era of ...